| Also known as |
Cabergoline |
| Blood pressure |
Can cause hypotension |
| Chemical name |
Cabergoline |
| Dosage (medical) |
0.25 mg to 1 mg twice a week |
| Dosage (sports) |
0.25 mg to 0.5 mg per week |
| Effects |
Decreases serum prolactin levels, can enhance mood, libido, and muscle growth indirectly by reducing prolactin |
| Formula |
C26H37N5O2 |
| Half-life |
63 to 69 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Prolactin levels |
| Main action |
Inhibits prolactin secretion in the pituitary's lactotroph cells |
| Side effects |
Nausea, headache, dizziness, orthostatic hypotension, constipation, and fatigue |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Ergoline derivative, Dopamine D2 receptor agonist |
| Trade name |
Dostinex, Cabaser |
| Use in sports |
Used by athletes to counteract prolactin-related side effects of certain steroids and performance-enhancing drugs |
| Water Retention |
No |
